Acquisition of Archipelago Aquiculture Group (“AAG”)

The information contained in this website is for general information purposes only. The information is provided by Ross Group Plc and while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website. Through this website you may be able to link to other websites which are not under the control of Ross Group Plc We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is hereby made to keep the website up and running as smoothly as possible. However, Ross Group Plc takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

Ross Group Plc (LSE: RGP) is pleased to announce that it has, as of January 2019, completed the acquisition of the entire issued share capital of Archipelago Aquaculture Group LLC.("AAG") from Global Blue Technologies Group, Inc ("GBTGI") (the "Acquisition") and is planning to start producing revenue in the near future, having already achieved proof of concept in its specialized extraction of Chitin, which is understood to be one of the most environmentally-friendly and economically effective extraction processes within the industry.

GBTGI and its affiliate subsidiaries are an international Group of companies that have created the world's first commercially viable bio-secure recyclable aquaculture system ("RAS") for the production of high quality, high value and accredited best-tasting organic colossal and extra colossal shrimp. AAG contains the start-up businesses of Mari Signum Limited, Mari Signum Dragon Drying-MS LLC, Mari Signum Mid-Atlantic LLC and Prometheus Progeniture Genetics Technologies Limited LLC, which are all specific supply chain companies involved in the research, development and production of Chitin, one of the main component in the exoskeletons of crustaceans and other arthropods.

Chitin is a natural bio-degradable polymer with the potential to transform the plastics, agricultural, veterinary, textile, cosmetic and pharmaceutical industries. AAG intends to focus on providing the highest possible quality Chitin to targeted pharmaceutical customers on a very selective strategic basis.

Chitin is found in the exoskeletons of arthropods (shrimp, crab, lobster, insects), and is one of the most abundant, organic bio-polymers found in nature (second to cellulose). Polymers are chains of molecules, the makeup of which determines the characteristics and beneficial properties of the materials in which the polymers are found: stiffness, strength, elasticity and toughness – as well as health, environmental and therapeutic benefits.

Chitin is a stable bio-polymer that is fully biodegradable with the potential to replace standard petrochemical plastic. Its unique molecular properties can be harnessed to innovate and revolutionize industries such as biotech, industrial filtration, medical and textiles.

Mari Signum is a chitin and chitin derivative production/processing company using a proprietary ionic liquid extraction process. It is the only commercially viable, environmentally responsible and U.S. government approved process for extracting high-quality chitin supplied by nature.

Dream ESG Investment

• Nontoxic proprietary extraction methods -Chitin’s bio-polymer will impact the human world in beneficial ways

• A company guided by the ‘Triple Bottom Line’ of environmental stewardship, social equity and ethical capitalism.

• Run by competent and conscientious local management

• High growth with high margins expected

• EBITA projection at 12 million in 2019, $18 million in 2020 and $30 million in 2021

• Mari Signum has the proprietary technologies to dry shell biomass materials locally, eliminating the wasteful disposal of decaying shrimp shells collected as industrial waste

Winner of the 2018 Green Chemistry Award

Mari Signum has received the prestigious 2018 Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in recognition of its unique technology that allows the sustainable isolation & extraction of the chitin polymer from crustacean shell biomass. The Green Chemistry Challenge Award program is in partnership with the American Chemical Society (ACS), and past winners of this annual EPA award include Merck, Amgen, Dow Chemical, Kraton Performance Polymers, Codexis, BASF, Dupont, Cargill and Bayer Corporation.

Mari Signum Business Strategy

• Mari Signum Mid-Atlantic LLC, is based in Richmond, VA, U.S.A. The current facility has the ability to expand production as the market demand grows.

• Mari Signum is strategically positioned with shell biomass supply from partnerships with Global Blue Technologies as well as sourcing from 3rd parties -Mari Signum will produce the world’s highest quality chitin from the GBT shell biomass, unlocking high end markets in bio pharma, medical and dental industries. Sector focus will evolve from

Short Term
Agriculture, Filtration (est $742/kg or $ 337 lb)

Mid Term
Cosmetics, Textiles, Bio Polymer Plastics

Long Term
Medical, Bio Pharma, Dental (est $ 22,000/kg or $10,000 lb)

Mari Signum Mid-Atlantic LLC, has finished its final trials and started commercial production of chitin Thursday Dec 27th, 2018. Ross Group Plc is positioned to create a sustainable bio-polymer solution for the world.